A novel cause of DKC1‐related bone marrow failure: Partial deletion of the 3′ untranslated region
暂无分享,去创建一个
J. Arthur | H. Pickett | R. Reddel | J. Christodoulou | D. Powell | T. Beilharz | B. Bennetts | T. Bryan | K. Jones | J. Teo | J. Curtin | R. Vasireddy | P. Barbaro | T. Kilo | E. Hackett | Tatjana Kilo | Raja S Vasireddy
[1] S. Savage,et al. Germline mutation of MDM4, a major p53 regulator, in a familial syndrome of defective telomere maintenance , 2020, Science Advances.
[2] J. Shay,et al. Telomeres and telomerase: three decades of progress , 2019, Nature Reviews Genetics.
[3] S. Savage. Beginning at the ends: telomeres and human disease , 2018, F1000Research.
[4] J. Benítez,et al. Mutations in XLF/NHEJ1/Cernunnos gene results in downregulation of telomerase genes expression and telomere shortening , 2017, Human molecular genetics.
[5] Grace X. Y. Zheng,et al. Massively parallel digital transcriptional profiling of single cells , 2016, Nature Communications.
[6] R. Reddel,et al. The wide‐ranging clinical implications of the short telomere syndromes , 2016, Internal medicine journal.
[7] Alberto Angrisani,et al. Human dyskerin: beyond telomeres , 2014, Biological chemistry.
[8] Jiang Li,et al. Finding the lost treasures in exome sequencing data. , 2013, Trends in genetics : TIG.
[9] Semyon Kruglyak,et al. Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms , 2013, Bioinform..
[10] R. Cawthon,et al. Short telomere length, cancer survival, and cancer risk in 47102 individuals. , 2013, Journal of the National Cancer Institute.
[11] Sue Fletcher,et al. Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements , 2012, Cellular and Molecular Life Sciences.
[12] S. Savage,et al. The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita. , 2012, Human molecular genetics.
[13] E. Wahle,et al. Control of poly(A) tail length , 2011, Wiley interdisciplinary reviews. RNA.
[14] S. Savage,et al. The genetics and clinical manifestations of telomere biology disorders , 2010, Genetics in Medicine.
[15] Richard M. Cawthon,et al. Telomere length measurement by a novel monochrome multiplex quantitative PCR method , 2009, Nucleic acids research.
[16] Xiaodong Qi,et al. The Telomerase Database , 2007, Nucleic Acids Res..
[17] K. Collins,et al. Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. , 2007, Molecular cell.
[18] S. Chanock,et al. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. , 2007, Blood.
[19] N. Bache,et al. Protein Composition of Catalytically Active Human Telomerase from Immortal Cells , 2007, Science.
[20] E. Hiyama,et al. Telomere and telomerase in stem cells , 2007, British Journal of Cancer.
[21] K. Collins,et al. Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. , 2006, Genes & development.
[22] S. Kulkarni,et al. Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. , 2005, Blood.
[23] K. Collins,et al. Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita , 2004, Human Genetics.
[24] E. Hoffman,et al. Detection of Nonrandom X Chromosome Inactivation , 2002, Current protocols in human genetics.
[25] T. Vulliamy,et al. Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice , 2002, Oncogene.
[26] E. Stevens-Linders,et al. Acquired skewing of Lyonization remains stable for a prolonged period in healthy blood donors , 2002, Leukemia.
[27] T. Vulliamy,et al. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. , 2001, Blood cells, molecules & diseases.
[28] K. Collins,et al. A telomerase component is defective in the human disease dyskeratosis congenita , 1999, Nature.
[29] A. Poustka,et al. Dyskeratosis Congenita Caused by a 3′ Deletion: Germline and Somatic Mosaicism in a Female Carrier , 1999 .
[30] A. Poustka,et al. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. , 1999, American journal of human genetics.
[31] Jing Zhao,et al. Formation of mRNA 3′ Ends in Eukaryotes: Mechanism, Regulation, and Interrelationships with Other Steps in mRNA Synthesis , 1999, Microbiology and Molecular Biology Reviews.
[32] S. Klauck,et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions , 1998, Nature Genetics.
[33] T. Vulliamy,et al. Skewed X-inactivation in carriers of X-linked dyskeratosis congenita. , 1997, Blood.
[34] A. Ferraris,et al. Nonrandom X-chromosome inactivation in hemopoietic cells from carriers of dyskeratosis congenita. , 1997, American journal of human genetics.
[35] K. Devriendt,et al. Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. , 1997, American journal of human genetics.
[36] G. Church,et al. The genomic sequencing technique. , 1985, Progress in clinical and biological research.